Johnson & Johnson ROA 1986-2025 | JNJ
Current and historical return on assets (ROA) values for Johnson & Johnson (JNJ) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Johnson & Johnson ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2025-09-30 |
$25.12B |
$0.00B |
17.72% |
| 2025-06-30 |
$22.66B |
$193.39B |
12.16% |
| 2025-03-31 |
$21.81B |
$193.67B |
11.90% |
| 2024-12-31 |
$14.07B |
$180.10B |
7.91% |
| 2024-09-30 |
$14.68B |
$178.29B |
8.40% |
| 2024-06-30 |
$38.02B |
$181.09B |
22.15% |
| 2024-03-31 |
$38.48B |
$171.97B |
22.07% |
| 2023-12-31 |
$35.15B |
$167.56B |
19.49% |
| 2023-09-30 |
$34.62B |
$166.06B |
18.69% |
| 2023-06-30 |
$13.05B |
$191.69B |
6.96% |
| 2023-03-31 |
$12.72B |
$195.97B |
6.91% |
| 2022-12-31 |
$17.94B |
$187.38B |
9.99% |
| 2022-09-30 |
$19.16B |
$175.12B |
10.74% |
| 2022-06-30 |
$18.37B |
$177.72B |
10.24% |
| 2022-03-31 |
$19.83B |
$178.36B |
11.08% |
| 2021-12-31 |
$20.88B |
$182.02B |
11.76% |
| 2021-09-30 |
$17.88B |
$179.23B |
10.17% |
| 2021-06-30 |
$17.77B |
$176.44B |
10.23% |
| 2021-03-31 |
$15.12B |
$172.56B |
8.94% |
| 2020-12-31 |
$14.71B |
$174.89B |
8.93% |
| 2020-09-30 |
$16.99B |
$170.69B |
10.59% |
| 2020-06-30 |
$15.19B |
$158.38B |
9.69% |
| 2020-03-31 |
$17.17B |
$155.02B |
11.01% |
| 2019-12-31 |
$15.12B |
$157.73B |
9.78% |
| 2019-09-30 |
$14.15B |
$155.52B |
9.22% |
| 2019-06-30 |
$16.33B |
$155.12B |
10.64% |
| 2019-03-31 |
$14.68B |
$150.03B |
9.56% |
| 2018-12-31 |
$15.30B |
$152.95B |
9.86% |
| 2018-09-30 |
$1.54B |
$155.70B |
0.99% |
| 2018-06-30 |
$1.37B |
$155.37B |
0.88% |
| 2018-03-31 |
$1.25B |
$156.63B |
0.80% |
| 2017-12-31 |
$1.30B |
$157.30B |
0.85% |
| 2017-09-30 |
$15.83B |
$155.66B |
10.65% |
| 2017-06-30 |
$16.34B |
$152.81B |
11.28% |
| 2017-03-31 |
$16.51B |
$144.92B |
11.66% |
| 2016-12-31 |
$16.54B |
$141.21B |
11.86% |
| 2016-09-30 |
$15.94B |
$140.37B |
11.60% |
| 2016-06-30 |
$15.03B |
$139.81B |
11.08% |
| 2016-03-31 |
$15.55B |
$136.23B |
11.62% |
| 2015-12-31 |
$15.41B |
$133.41B |
11.69% |
| 2015-09-30 |
$14.72B |
$133.27B |
11.23% |
| 2015-06-30 |
$16.11B |
$132.04B |
12.32% |
| 2015-03-31 |
$15.92B |
$128.59B |
12.10% |
| 2014-12-31 |
$16.32B |
$130.36B |
12.30% |
| 2014-09-30 |
$17.32B |
$132.10B |
12.99% |
| 2014-06-30 |
$15.55B |
$135.20B |
11.78% |
| 2014-03-31 |
$15.06B |
$133.33B |
11.65% |
| 2013-12-31 |
$13.83B |
$132.68B |
10.94% |
| 2013-09-30 |
$12.88B |
$126.93B |
10.43% |
| 2013-06-30 |
$12.87B |
$124.33B |
10.59% |
| 2013-03-31 |
$10.44B |
$121.54B |
8.74% |
| 2012-12-31 |
$10.85B |
$121.35B |
9.19% |
| 2012-09-30 |
$8.50B |
$118.95B |
7.32% |
| 2012-06-30 |
$8.74B |
$115.75B |
7.64% |
| 2012-03-31 |
$10.11B |
$116.19B |
8.91% |
| 2011-12-31 |
$9.67B |
$113.64B |
8.68% |
| 2011-09-30 |
$11.40B |
$111.82B |
10.48% |
| 2011-06-30 |
$11.61B |
$112.11B |
11.02% |
| 2011-03-31 |
$12.28B |
$108.15B |
12.23% |
| 2010-12-31 |
$13.33B |
$102.91B |
13.79% |
| 2010-09-30 |
$13.60B |
$98.25B |
14.36% |
| 2010-06-30 |
$13.53B |
$92.30B |
14.54% |
| 2010-03-31 |
$13.29B |
$93.44B |
14.47% |
| 2009-12-31 |
$12.27B |
$94.68B |
13.64% |
| 2009-09-30 |
$12.77B |
$91.56B |
14.60% |
| 2009-06-30 |
$12.74B |
$87.44B |
14.72% |
| 2009-03-31 |
$12.86B |
$86.10B |
14.83% |
| 2008-12-31 |
$12.95B |
$84.91B |
14.94% |
| 2008-09-30 |
$12.61B |
$87.72B |
14.71% |
| 2008-06-30 |
$11.85B |
$88.11B |
14.20% |
| 2008-03-31 |
$11.60B |
$86.00B |
14.49% |
| 2007-12-31 |
$10.58B |
$80.95B |
13.76% |
| 2007-09-30 |
$10.37B |
$78.67B |
13.97% |
| 2007-06-30 |
$10.58B |
$74.68B |
15.14% |
| 2007-03-31 |
$10.32B |
$73.07B |
15.53% |
| 2006-12-31 |
$11.05B |
$70.56B |
17.34% |
| 2006-09-30 |
$10.98B |
$61.24B |
18.06% |
| 2006-06-30 |
$10.76B |
$60.99B |
18.04% |
| 2006-03-31 |
$10.53B |
$62.13B |
18.14% |
| 2005-12-31 |
$10.06B |
$58.86B |
17.93% |
| 2005-09-30 |
$8.85B |
$56.57B |
16.18% |
| 2005-06-30 |
$8.66B |
$54.55B |
16.15% |
| 2005-03-31 |
$8.53B |
$54.45B |
16.24% |
| 2004-12-31 |
$8.18B |
$53.32B |
16.00% |
| 2004-09-30 |
$9.14B |
$52.09B |
18.33% |
| 2004-06-30 |
$8.87B |
$50.17B |
18.29% |
| 2004-03-31 |
$7.62B |
$48.87B |
16.09% |
| 2003-12-31 |
$7.20B |
$48.26B |
15.77% |
| 2003-09-30 |
$6.74B |
$46.66B |
15.41% |
| 2003-06-30 |
$6.39B |
$45.65B |
15.32% |
| 2003-03-31 |
$6.83B |
$41.99B |
17.13% |
| 2002-12-31 |
$6.60B |
$40.56B |
16.93% |
| 2002-09-30 |
$6.32B |
$38.66B |
16.43% |
| 2002-06-30 |
$6.12B |
$38.35B |
16.09% |
| 2002-03-31 |
$5.95B |
$38.30B |
15.87% |
| 2001-12-31 |
$5.67B |
$38.49B |
15.80% |
| 2001-09-30 |
$5.45B |
$37.05B |
15.66% |
| 2001-06-30 |
$5.25B |
$36.10B |
15.78% |
| 2001-03-31 |
$5.13B |
$31.88B |
16.13% |
| 2000-12-31 |
$4.89B |
$34.25B |
15.61% |
| 2000-09-30 |
$4.75B |
$30.78B |
15.82% |
| 2000-06-30 |
$4.54B |
$30.31B |
15.46% |
| 2000-03-31 |
$4.34B |
$29.96B |
15.19% |
| 1999-12-31 |
$4.17B |
$29.16B |
15.00% |
| 1999-09-30 |
$3.52B |
$28.11B |
13.00% |
| 1999-06-30 |
$3.37B |
$27.13B |
13.03% |
| 1999-03-31 |
$3.22B |
$26.75B |
13.07% |
| 1998-12-31 |
$3.00B |
$26.21B |
12.81% |
| 1998-09-30 |
$3.53B |
$23.33B |
15.87% |
| 1998-06-30 |
$3.42B |
$22.31B |
15.67% |
| 1998-03-31 |
$3.31B |
$21.92B |
15.40% |
| 1997-12-31 |
$3.30B |
$21.45B |
15.59% |
| 1997-09-30 |
$3.23B |
$21.68B |
15.50% |
| 1997-06-30 |
$3.12B |
$21.01B |
15.32% |
| 1997-03-31 |
$3.01B |
$20.62B |
15.06% |
| 1996-12-31 |
$2.89B |
$20.01B |
14.77% |
| 1996-09-30 |
$2.80B |
$19.91B |
14.71% |
| 1996-06-30 |
$2.67B |
$19.31B |
14.46% |
| 1996-03-31 |
$2.54B |
$18.94B |
14.13% |
| 1995-12-31 |
$2.40B |
$17.87B |
13.81% |
| 1995-09-30 |
$2.32B |
$17.69B |
13.75% |
| 1995-06-30 |
$2.22B |
$17.39B |
13.75% |
| 1995-03-31 |
$2.12B |
$16.64B |
13.97% |
| 1994-12-31 |
$2.01B |
$15.67B |
14.13% |
| 1994-09-30 |
$1.96B |
$14.83B |
14.72% |
| 1994-06-30 |
$1.89B |
$13.44B |
14.87% |
| 1994-03-31 |
$1.83B |
$12.83B |
14.72% |
| 1993-12-31 |
$1.79B |
$12.24B |
14.64% |
| 1993-09-30 |
$1.76B |
$12.40B |
14.52% |
| 1993-06-30 |
$1.72B |
$12.21B |
14.36% |
| 1993-03-31 |
$1.68B |
$11.96B |
14.30% |
| 1992-12-31 |
$1.65B |
$11.88B |
14.53% |
| 1992-09-30 |
$1.62B |
$11.81B |
14.68% |
| 1992-06-30 |
$1.57B |
$11.24B |
14.88% |
| 1992-03-31 |
$1.52B |
$10.46B |
15.09% |
| 1991-12-31 |
$1.46B |
$10.51B |
14.95% |
| 1991-09-30 |
$1.42B |
$9.85B |
14.90% |
| 1991-06-30 |
$1.37B |
$9.43B |
14.51% |
| 1991-03-31 |
$1.32B |
$9.29B |
14.04% |
| 1990-12-31 |
$1.14B |
$9.51B |
12.40% |
| 1990-09-30 |
$1.11B |
$9.55B |
12.63% |
| 1990-06-30 |
$1.07B |
$9.17B |
12.78% |
| 1990-03-31 |
$1.01B |
$8.64B |
12.70% |
| 1989-12-31 |
$1.08B |
$7.92B |
14.19% |
| 1989-09-30 |
$1.06B |
$7.61B |
14.32% |
| 1989-06-30 |
$1.04B |
$7.60B |
14.32% |
| 1989-03-31 |
$1.01B |
$7.36B |
14.22% |
| 1988-12-31 |
$0.97B |
$7.12B |
13.88% |
| 1988-09-30 |
$0.95B |
$6.90B |
13.86% |
| 1988-06-30 |
$0.92B |
$7.09B |
13.51% |
| 1988-03-31 |
$0.88B |
$6.97B |
13.10% |
| 1987-12-31 |
$0.83B |
$6.55B |
12.81% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
